Consistent with our results, the study by Sugihara, T. et al. found that DLG1 loss was associated with poor prognosis in endometrial cancer and that knocking down DLG1 accelerated tumor migration and invasion in vitro [29]. This evidence concerns the gene DLG1 and endometrial cancer.